Neuroendocrine findings in anxiety disorders

Neurol Clin. 1988 Feb;6(1):131-48.

Abstract

Anxiety disorders are newly defined syndromes in which inappropriate state anxiety is the sole or primary symptom. Hormonal manifestations of acute stress are usually minimal or absent in these disorders. A number of findings suggest receptor downregulation or enzyme induction of sorts that would be expected to mute or dampen these responses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Anxiety Disorders / blood*
  • Anxiety Disorders / classification
  • Catecholamines / blood
  • Growth Hormone / blood
  • Humans
  • Hydrocortisone / blood
  • Methoxyhydroxyphenylglycol / blood
  • Neurosecretory Systems / metabolism
  • Neurosecretory Systems / physiopathology*
  • Obsessive-Compulsive Disorder / blood
  • Stress, Psychological / blood

Substances

  • Catecholamines
  • Methoxyhydroxyphenylglycol
  • Adrenocorticotropic Hormone
  • Growth Hormone
  • Hydrocortisone